Swiss National Bank
CRMD icon

Swiss National Bank’s CorMedix CRMD Stock Holding History

Swiss National Bank’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$993K Hold
146,200
– – ﹤0.01% 2160
2025
Q4 		$1.7M Hold
146,200
– – ﹤0.01% 1944
2025
Q3 		$1.7M Buy
146,200
+28,600
+24% +$346K ﹤0.01% 1933
2025
Q2 		$1.45M Hold
117,600
– – ﹤0.01% 1966
2025
Q1 		$724K Buy
+117,600
New +$1.22M ﹤0.01% 2263

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Swiss National Bank's CRMD Position: Q1 2026 in Review

Swiss National Bank held its CorMedix (CRMD) position steady in Q1 2026 at 146,200 shares worth $993K. The position accounts for ﹤0.01% of the portfolio, ranked #2160.

Swiss National Bank first reported a position in CRMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.7M in Q4 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Swiss National Bank held 146,200 shares of CorMedix worth $993K as of Q1 2026.
  • Swiss National Bank left its CorMedix share count unchanged in Q1 2026.
  • CorMedix made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #2160 holding.
  • Swiss National Bank first reported a position in CorMedix in Q1 2025 and has held it in 5 quarters since.
  • Swiss National Bank's CorMedix position peaked at $1.7M in Q4 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.